Dipyridamole and low-dose warfarin without cyclophosphamide in the management of IgA nephropathy [4] (multiple letters)

Kidney International

Volumn 57, Issue 1, 2000, Pages 348-349

  Woo, K T ^a   Lee, G S L ^a   Pall, A A ^a   Courteau, M ^a   Nolin, L ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DIPYRIDAMOLE; WARFARIN;

IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; PRIORITY JOURNAL; PROTEINURIA; TREATMENT PLANNING;

EID: 0034047550     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00843.x     Document Type: Letter

References (6)

1. L. Nolin M. Courteau Management of IgA nephropathy: Evidence-based recommendations Kidney Int 55 Suppl 70 1999 S56 S62
2. K.T. Woo R.P.S. Edmondson H.K. Yap A.Y.T. Wu G.S.C. Chiang H.S. Pwee C.H. Lim Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis Clin Nephrol 27 1987 56 64
3. R.G. Walker S.H. Yu J.E. Owen P. Kincaid-Smith The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: A two-year prospective trial Clin Nephrol 34 1990 103 107
4. K.T. Woo G.S.L. Lee Y.K. Lau G.S.C. Chiang C.H. Lim Effects of triple therapy in IgA nephritis: A follow up study 5 years later Clin Nephrol 36 1991 60 66
5. K.T. Woo G.S.C. Chiang C.H. Lim Follow up renal biopsies in IgA nephritis patients on triple therapy Clin Nephrol 28 1987 304 305
6. G.S.L. Lee H.L. Choong G.S.C. Chiang K.T. Woo Three-year randomized controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephropathy and renal impairment Nephrology 3 1997 117 121